651 related articles for article (PubMed ID: 16760444)
1. Major congenital malformations after first-trimester exposure to ACE inhibitors.
Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
3. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
de Leeuw PW
Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
[TBL] [Abstract][Full Text] [Related]
4. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.
Li DK; Yang C; Andrade S; Tavares V; Ferber JR
BMJ; 2011 Oct; 343():d5931. PubMed ID: 22010128
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
6. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
Walfisch A; Al-maawali A; Moretti ME; Nickel C; Koren G
J Obstet Gynaecol; 2011 Aug; 31(6):465-72. PubMed ID: 21823839
[TBL] [Abstract][Full Text] [Related]
7. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors and birth defects.
Prescrire Int; 2006 Dec; 15(86):223. PubMed ID: 17167930
[No Abstract] [Full Text] [Related]
9. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
[TBL] [Abstract][Full Text] [Related]
10. Bupropion in pregnancy and the prevalence of congenital malformations.
Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Schaefer C
Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
[TBL] [Abstract][Full Text] [Related]
12. Beta2-agonists use during pregnancy and the risk of congenital malformations.
Eltonsy S; Forget A; Blais L
Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
[TBL] [Abstract][Full Text] [Related]
13. The safety of metoclopramide use in the first trimester of pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
[TBL] [Abstract][Full Text] [Related]
14. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
[TBL] [Abstract][Full Text] [Related]
15. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
Piper JM; Ray WA; Rosa FW
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
[TBL] [Abstract][Full Text] [Related]
17. Folic acid antagonists during pregnancy and the risk of birth defects.
Hernández-Díaz S; Werler MM; Walker AM; Mitchell AA
N Engl J Med; 2000 Nov; 343(22):1608-14. PubMed ID: 11096168
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitors and major congenital malformations.
Sealey JE; Itskovitz-Eldor J
N Engl J Med; 2006 Sep; 355(12):1280-1; author reply 1281. PubMed ID: 16990393
[No Abstract] [Full Text] [Related]
19. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns.
Nakhai-Pour HR; Rey E; Bérard A
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):147-54. PubMed ID: 20437474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
